Registration: Role of Molecular Imaging in AD and Dementia
To provide up-to-date information to primary care physicians, neurologists, psychiatrists and geriatricians about the clinical utility and availability molecular neuroimaging studies in the evaluation of patients with suspected dementia, SNMMI is holding an evening symposium at the University of Pennsylvania (UPenn). This event will offer free CME for participants over dinner and will capture learning metrics via an audience response system.